ask="N/A"
ask_size="N/A"
average_daily_volume="233220"
bid="25.00"
bid_size="100"
book_value="6.63"
change="+1.30"
change_from_200_day_moving_average="0.08"
change_from_50_day_moving_average="0.46"
change_from_52_week_high="-7.43"
change_From_52_week_low="16.49"
change_in_percent="+4.31%"
close="31.49"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.26"
ebitda="-177.35M"
eps_estimate_current_year="-4.40"
eps_estimate_next_quarter="-1.10"
eps_estimate_next_year="-4.07"
ex_dividend_date="N/A"
float_shares="30861000"
high="31.61"
high_52_weeks="38.92"
last_trade_date="3/15/2017"
last_trade_price="31.49"
last_trade_size="11986"
last_trade_time="4:00pm"
low="30.16"
low_52_weeks="15.00"
market_capitalization="1.66B"
moving_average_200_day="31.41"
moving_average_50_day="31.03"
name="Theravance Biopharma
Inc."
notes="N/A"
one_year_target_price="34.86"
open="30.30"
pe_ratio="N/A"
peg_ratio="-0.02"
percent_change_from_200_day_moving_average="+0.26%"
percent_change_from_50_day_moving_average="+1.49%"
percent_change_from_52_week_high="-19.09%"
percent_change_from_52_week_low="+109.93%"
previous_close="30.19"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.55"
price_per_sales="32.80"
revenue="48.65M"
shares_outstanding="52855000"
short_ratio="23.69"
stock_exchange="NGM"
symbol="TBPH"
volume="151238"
weeks_range_52="15.00 - 38.92"
